Innovative Research Product References-August Publications

x

Written by Kelsey on September 16, 2014. Posted in Blog

Human Serum


(August 1, 2014) Innovative Research Pooled Normal Human Serum was recently used in the following study:

A comparison of drug-induced cardiotoxicity in rat embryos cultured in human serum or protein free media

HE Ritchie, CH Svensson, MF Nilsson, WS Webster - Journal of Pharmacological and , 2014
...vitamins, inorganic salts supplemented with 4500 mg/L, glucose. The pooled, normal human serum (Innovative Research, Novi, MI 48377) was heat inactivated (56 C for 30 minutes) and supplemented with glucose (3 mg/ml). ...



(August 4, 2014) Innovative Research Human Receptor Associated Protein (RAP) was recently used in the following study:

APOE genotypedependent modulation of astrocyte chemokine CCL3 production

E Cudaback, Y Yang, TJ Montine, CD Keene - Glia, 2014
from Calbiochem (La Jolla, CA, USA); Pam3CSK4 (Pam3) and CpG oligonucleotides were purchased from Invivogen (San Diego, CA, USA); low endotoxin recombinant human receptor associated protein (RAP) was purchased from Innovative Research (Novi, MI, USA) ...



(August 8, 2014) Innovative Research Human Factor X was recently used in the following study:

Inhibition of tf: fviiacatalysed fix and fx activation by tfpi and tfpi constructs

Peraramelli, S Thomassen, A Heinzmann, J Rosing - Journal of Thrombosis and , 2014
Effect of TFPI on FIX and FX activation * Editorial correspondence and proofs to: Tilman M. Hackeng ... IN, USA). FX was purchased from Innovative Research (Novi, MI, USA). FIX, FIXa and protein S were ...



(August 13, 2014) Innovative Research Human Neutrophil Elastase was recently used in the following study:

Characterization of physical properties of tissue factor containing microvesicles and a comparison of ultracentrifuge-based recovery procedures

C Ettelaie, MEW Collier, A Maraveyas, R Ettelaie - Journal of Extracellular Vesicles, 2014
TF-tGFP possessed similar TF activity to unconjugated TF, in agreement with our previous data (8). Microvesicles were also recovered from the plasma of diseased (colorectal cancer and cardiovascular patients) or normal subjects (Innovative Research, Novi, MI, USA) (11) and ...



(August 15, 2014) Innovative Research Human Neutrophil Elastase was recently used in the following study:

Cecropin A-melittin mutant with improved proteolytic stability and enhanced antimicrobial activity against bacteria and fungi associated with gastroenteritis in vitro

S Ji, W Li, L Zhang, Y Zhang, B Cao - Biochemical and Biophysical Research , 2014
Louis, MO), pepsin (Sigma), human neutrophil elastase (HNE; Innovative Research, Novi, MI), P. aeruginosa elastase (PE; Innovative Research), and S. aureus V8 protease (V8; BioCol GmbH) with a substrate: enzyme molar ratio of 300:1 at 37 C for 30 min. ...



(August 22, 2014) Innovative Research Pooled Normal Human Serum was recently used in the following study:

Encapsulation of adenovirus serotype 5 in anionic lecithin liposomes using a bead-based immunoprecipitation technique enhances transfection efficiency

N Mendez, V Herrera, L Zhang, F Hedjran, R Feuer - Biomaterials, 2014
Serum-induced particle aggregation. Human serum (Innovative Research, Novi, MI) was incubated in 96-well plates at 37 C and 5% CO 2 for 1 h before use for decomplementation....



(August 28, 2014) Innovative Research Pooled Normal Human Plasma was recently used in the following study:

Bioinspired affinity DNA polymers on nanoparticles for drug sequestration and detoxification

N Chen, Y Huang, Y Wang - Biomaterials, 2014
The pooled normal human plasma (supplemented with sodium heparin) was ordered from Innovative research (Novi, MI). ...

© 2018 Innovative Research. All Rights Reserved.